Insight Venture lists HNGE Class A share sales

Insight Venture Partners reported multiple proposed sales of Hinge Health, Inc. Class A common stock.

Rhea-AI Filing Summary

Insight Venture Partners reported multiple proposed sales of Hinge Health, Inc. Class A common stock. The filing lists planned brokered sales on 06/16/2026, 06/22/2026, 06/23/2026, 06/24/2026, and 06/25/2026 with individual share amounts and gross proceeds shown for each date. The transactions are reported on Form 144 and identify Raymond James & Associates as the broker.

Insights

Securities Counsel

Routine resale notices by a selling holder under Form 144; disclosures show dates, share counts, and gross proceeds.

The submission lists multiple dated proposed sales of Class A common by Insight Venture Partners (Cayman) X, L.P., with per‑date share quantities and gross dollar amounts recorded. The broker named is Raymond James & Associates.

These filings are procedural disclosures of intended resales. Cash‑flow treatment and any limits on timing are not detailed in the excerpt; subsequent transaction reports would show completed sales and actual proceeds.

Key Figures

06/16/2026 sale: 26,856 shares 06/22/2026 sale: 91,893 shares 06/23/2026 sale: 46,060 shares +3 more

6 metrics

06/16/2026 sale 26,856 shares listed with gross proceeds $1,889,577.42

06/22/2026 sale 91,893 shares listed with gross proceeds $6,520,185.11

06/23/2026 sale 46,060 shares listed with gross proceeds $3,234,079.87

06/24/2026 sale 218,362 shares listed with gross proceeds $15,550,256.78

06/25/2026 sale 217,442 shares listed with gross proceeds $15,617,445.49

Form type Form 144 Notice of proposed sale by an affiliate

Key Terms

Form 144, Class A common, Stock conversion before IPO, Wired to portfolio company

4 terms

Form 144 regulatory

"The filing entries list proposed sales and broker details on Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Class A common financial

"Each sale line identifies the security as Class A common"

Stock conversion before IPO corporate

"Line notes 'STOCK CONVERSION BEFORE IPO' dated 07/03/2018"

Wired to portfolio company financial

"Entry shows 'WIRED TO PORTFOLIO COMPANY' with a 07/03/2018 date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HNGE Form 144 show about Insight Venture Partners' activity?

It reports proposed sales of Hinge Health Class A common shares on several dates in June 2026. The filing lists per‑date share counts and gross proceeds for each planned sale, and names Raymond James & Associates as the broker.

How many shares did Insight Venture Partners offer on 06/24/2026 for HNGE?

The filing lists a proposed sale of 218,362 shares on 06/24/2026. The same line shows gross proceeds of $15,550,256.78 associated with that date in the excerpt.

Does the Form 144 state who receives the sale proceeds for HNGE shares?

The excerpt identifies Insight Venture Partners (Cayman) X, L.P. as the selling holder. It does not state the recipient of proceeds beyond listing the selling entity and broker in the provided lines.

Are the listed transactions on HNGE already completed according to the filing?

No; the Form 144 entries record proposed or reported sales with dates and amounts. Completion status or settlement details are not provided in the excerpt and would appear in subsequent transaction reports.

Which broker is named for the HNGE sales listed in the filing?

The filing names Raymond James & Associates at 880 Carillon Pkwy, St. Petersburg, FL as the broker associated with the Class A common sales shown in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:47 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710860
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners (Cayman) X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
CLASS A COMMON	RAYMOND JAMES & ASSOCIATES 880 CARILLON PKWY ST. PETERSBURG FL 33716	600613	48049040.00	55883690	06/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
CLASS A COMMON	07/03/2018	STOCK CONVERSION BEFORE IPO	HINGE HEALTH, INC.			4485644	07/03/2018	WIRED TO PORTFOLIO COMPANY

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas, 36th Floor NEW YORK NY 10036	CLASS A COMMON	06/16/2026	26856	1889577.42
Insight Venture Partners (Cayman) X, L.P. 1114 AVENUE OF AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/22/2026	91893	6520185.11
Insight Venture Partners (Cayman) X, L.P. 1114 AVENUE OF AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/23/2026	46060	3234079.87
Insight Venture Partners (Cayman) X, L.P. 1114 AVENUE OF THE AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/24/2026	218362	15550256.78
Insight Venture Partners (Cayman) X, L.P. 1114 AVENUE OF THE AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/25/2026	217442	15617445.49

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	MOHAMMED ALSHATRI, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Insight Venture Partners (Cayman) X,
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)